Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-03

Clinical Trial Update: EFFECTS OF A YERBA MATE EXTRACT IN REDUCING METABOLIC SYNDROME IN OVERWEIGHT INDIVIDUALS [NA]

View source ↗

Summary

A clinical trial is evaluating whether yerba mate extract can reduce metabolic syndrome features in overweight individuals; enrollment is by invitation and the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Yerba mate extract (Ilex paraguariensis extract)

Snippet

Sponsor: Universidade Federal da Fronteira Sul | Conditions: Metabolic Syndrome, Diabetes | NA | Status: ENROLLING_BY_INVITATION